Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Poland / NCT07726121
Recruiting Observational

Anatomical and Imaging Assessment of the Alveolar Antral Artery Canal Using CBCT

NCT07726121 · tracked via the Priya Life Science Poland tracker
Sponsor
Hospital of the Ministry of Interior, Kielce, Poland
Phase
Observational
Started
2026-07-01
Last updated
2026-09-18

Condition(s) studied

Maxillary SinusCone-Beam Computed TomographyArtery

Investigational drug(s) / intervention(s)

Assigned Interventions

Assigned Interventions: Assigned Interventions

Study summary

This research project aims to improve understanding of the alveolar antral artery canal, an anatomical structure located in the maxilla, using cone-beam computed tomography (CBCT). The project includes several studies examining the canal's anatomy and anatomical variations, as well as evaluating different CBCT-based methods for identifying and mapping the canal. The findings will help determine the accuracy and usefulness of these imaging approaches and may improve preoperative assessment and surgical planning for procedures involving the maxilla.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * CBCT scans acquired following a written referral from a physician or dentist. * Complete visualization of the alveolar antral artery canal and the maxillary sinus region. * Sufficient image quality to allow reliable anatomical assessment. Exclusion Criteria: * CBCT scans with significant imaging artefacts affecting visualization of the alveolar antral artery canal. * Previous surgical procedures or pathological lesions in the region of interest that preclude reliable anatomical assessment. * Incomplete visualization of the region of interest.

Primary outcome measure(s)

  • Anatomical Characteristics of the Alveolar Antral Artery Canal — Baseline

Trial sites (1)

FacilityCityRegionStatus
Department of Maxillofacial Surgery, Hospital of the Ministry of Interior Kielce Poland Recruiting

More Hospital of the Ministry of Interior, Kielce, Poland trials in Poland

Large Language Models for Dental Radiology Report Generation From Structured Textual Data Recruiting
Analysis of Tooth Root Number Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07726121 on ClinicalTrials.gov ↗ ← All trials in Poland